Table 1.
Characteristics of PCOS cases and controls.
| PCOS (n=202) | Controls (n=34) | P | |
|---|---|---|---|
| Age (years) | 30.78 ± 3.66 | 31.94 ± 3.56 | 0.042 |
| BMI (kg/m2) | 25.08 ± 4.66 | 23.73 ± 4.26 | 0.117 |
| Follicle-stimulating hormone (IU/L) | 5.22 ± 1.45 | 6.14 ± 2.29 | 0.055 |
| Luteinizing hormone (IU/L) | 7.12 ± 4.49 | 3.97 ± 2.16 | <0.001 |
| Total testosterone (ng/dL) | 46.86 ± 17.95 | 24.18 ± 8.03 | <0.001 |
| Sex hormone-binding globulin(nmol/L) | 57.46 ± 60.56 | 44.67 ± 28.89 | 0.811 |
| Free androgen index | 5.40 ± 4.73 | 2.69 ± 1.98 | 0.002 |
| Anti-Müllerian hormone (ng/mL) | 8.25 ± 5.34 | 2.13 ± 0.87 | <0.001 |
| Fasting glucose (mmol/L) | 5.26 ± 1.34 | 4.94 ± 0.59 | 0.086 |
| Fasting insulin(mIU/L) | 13.69 ± 8.82 | 12.04 ± 7.27 | 0.327 |
| HOMA-IR | 3.32 ± 2.64 | 2.73 ± 1.89 | 0.187 |
| Leptin (ng/mL) | 34.88 ± 14.06 | 22.41 ± 14.57 | <0.001 |
| Adiponectin (μg/mL) | 33.79 ± 15.40 | 38.96 ± 13.53 | 0.082 |
| Log10total SFAs (μg/mL) | 3.17 ± 0.10 | 3.06 ± 0.12 | <0.001 |
| Log10total MUFAs (μg/mL) | 2.48 ± 0.18 | 2.68 ± 0.17 | <0.001 |
| Log10total TFAs (μg/mL) | 1.77 ± 0.26 | 1.70 ± 0.13 | 0.008 |
| Log10total PUFAs (μg/mL) | 2.57 ± 0.16 | 2.71 ± 0.19 | <0.001 |
PCOS, polycystic ovary syndrome; BMI, body mass index; HOMA-IR, homeostasis model assessment for insulin resistance; SFAs, saturated fatty acids; MUFAs, monounsaturated fatty acids; PUFAs, polyunsaturated fatty acids; TFAs, trans fatty acids.